SCHEMBL17615841

SCHEMBL17615841

CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)NCCCC(=O)Nc1ccc(O)c(C(=O)O)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX12 P18054 2/20 0.54
▸ MAPT P10636 3/20 0.53
▸ CNR1 P21554 5/20 0.48
▸ CNR2 P34972 3/20 0.48
▸ ALDH1A1 P00352 4/20 0.48
▸ KDM4C Q9H3R0 2/20 0.47
▸ EPHX2 P34913 2/20 0.47
▸ FAAH O00519 1/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ HPGD P15428 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ TRPV1 Q8NER1 2/20 0.45
▸ PSMB11 A5LHX3 1/20 0.45
▸ PSMA7 O14818 1/20 0.45
▸ TP53 P04637 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ ALOX15 P16050 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL455989 0.91 KDM4C (0.55) ALOX12MAPTCNR1CNR2ALDH1A1
SCHEMBL469470 0.91 KDM4C (0.55) ALOX12MAPTCNR1CNR2ALDH1A1
SCHEMBL2677643 0.89 CNR1 (0.59) MAPTCNR1CNR2ALDH1A1KDM4C
SCHEMBL2677644 0.89 CNR1 (0.59) MAPTCNR1CNR2ALDH1A1KDM4C
SCHEMBL13540506 0.88 ALOX12 (0.55) ALOX12MAPTCNR1CNR2ALDH1A1
SCHEMBL1822295 0.88 ALDH1A1 (0.54) ALOX12MAPTCNR1CNR2ALDH1A1
SCHEMBL1822294 0.88 ALDH1A1 (0.54) ALOX12MAPTCNR1CNR2ALDH1A1
SCHEMBL1822036 0.87 CNR1 (0.57) MAPTCNR1CNR2ALDH1A1KDM4C
SCHEMBL1822035 0.87 CNR1 (0.57) MAPTCNR1CNR2ALDH1A1KDM4C
SCHEMBL17615836 0.86 KDM4C (0.52) ALOX12MAPTCNR1CNR2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160083336-A1 FATTY ACID ACYLATED SALICYLATES AND THEIR USES CATABASIS PHARMACEUTICALS, INC. 2016-03-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160083336-A1 FATTY ACID ACYLATED SALICYLATES AND THEIR USES FADS1, FASN, ALOX5 ALOX12 12/4885MAPT 2685/4885CNR1 1031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback